Streetbeat News

Products Services

BGNE

The FDA has accepted BeiGene's supplemental new drug application for Brukinsa (Zanubrutinib) combined with Obinutuzumab for relapsed or refractory follicular lymphoma. The target action date is in Q1 2024.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 11:14 am

GRMN

Garmin (NYSE:GRMN), a leading marine electronics manufacturer, has been selected by Sportsman Boats as the exclusive supplier of Fusion® Entertainment marine audio packages for its full line of offshore center consoles and inshore bay boats starting from model year 2024. The deal includes stereos, speakers, subwoofers, and amplifiers for 16 models across Sportsman's Open, Heritage, and Masters series.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 11:09 am

DPZ

UBER

Domino's Pizza Inc. (DPZ) has entered into a global agreement with Uber (UBER) to allow U.S. customers to order Domino's products through the Uber Eats and Postmates apps. The initial rollout will begin this fall in four pilot markets, with nationwide availability expected by the end of 2023.

Portfolio Pulse from Charles Gross

July 12, 2023 | 11:09 am

KMDA

Kamada Ltd. (NASDAQ:KMDA) announced that Kedrion has exercised its option to extend the distribution agreement for KEDRAB in the U.S. through March 2026. The companies are also in discussions to potentially expand the scope of their collaboration.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 11:08 am

GOEV

Canoo has delivered three crew transportation vehicles to NASA's Kennedy Space Center in Florida. These vehicles will be used to transport astronauts to the launch pad for the Artemis lunar missions.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 11:07 am

LPTX

Leap Therapeutics has initiated the randomized controlled Part B of its Phase 2 study, which involves 130 patients. The study is evaluating Leap's DKN-01 antibody in combination with standard of care bevacizumab and chemotherapy as a second-line treatment for patients with advanced CRC.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 11:04 am

PLTR

Palantir Technologies Inc. (PLTR) and AirMatrix, a Toronto-based startup, have announced a strategic partnership to accelerate and scale drone operations. The partnership will leverage Palantir Foundry through the Foundry for Builders Program, providing AirMatrix's clients with airspace security, threat detection, compliance enablement, and risk mitigation.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 11:01 am

PLUG

Plug Power, Inc. (NASDAQ:PLUG) has been chosen by Australia's Countrywide Hydrogen to supply two 5-megawatt proton exchange membrane electrolyzer systems for green hydrogen projects in Tasmania. The electrolyzer systems will be installed at planned production facilities in Brighton and Western Junction. The sites will connect to the TasGas network, allowing the injection of hydrogen into the network and supply to local industry. The hydrogen produced will decarbonize Tasmania's road transport and natural gas sectors.

Portfolio Pulse from Nabaparna Bhattacharya

July 12, 2023 | 10:55 am

AZN

AstraZeneca and Daiichi Sankyo's Enhertu has been approved in China for the treatment of adult patients with unresectable or metastatic HER2-low breast cancer. The approval by China's National Medical Products Administration is based on the results of the DESTINY-Breast04 Phase III trial.

Portfolio Pulse from Charles Gross

July 12, 2023 | 10:37 am

AKAM

Akamai Technologies has launched three new cloud computing sites, marking a significant step in the company's push to offer compute, storage, database, and other services.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 10:36 am